Fisher information matrix for nonlinear mixed effects multiple response models: Evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model
暂无分享,去创建一个
[1] É. Moulines,et al. Convergence of a stochastic approximation version of the EM algorithm , 1999 .
[2] Malcolm Rowland,et al. Optimal Design for Multivariate Response Pharmacokinetic Models , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[3] Mats O. Karlsson,et al. Comparison of some practical sampling strategies for population pharmacokinetic studies , 1996, Journal of Pharmacokinetics and Biopharmaceutics.
[4] Eric Walter,et al. Identification of Parametric Models: from Experimental Data , 1997 .
[5] France Mentré,et al. Optimization of Individual and Population Designs Using Splus , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[6] Jon Wakefield,et al. Population modelling in drug development , 1999, Statistical methods in medical research.
[7] Paolo Vicini,et al. Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments , 2005, The AAPS Journal.
[8] Anthony C. Atkinson,et al. Optimum Experimental Designs , 1992 .
[9] France Mentré,et al. Fisher information matrix for non‐linear mixed‐effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics , 2002, Statistics in medicine.
[10] France Mentré,et al. Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs , 2001, Comput. Methods Programs Biomed..
[11] Lewis B. Sheiner,et al. Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[12] Michel Tod,et al. Impact of Pharmacokinetic–Pharmacodynamic Model Linearization on the Accuracy of Population Information Matrix and Optimal Design , 2001, Journal of Pharmacokinetics and Pharmacodynamics.
[13] D. Bates,et al. Approximations to the Log-Likelihood Function in the Nonlinear Mixed-Effects Model , 1995 .
[14] D. Bates,et al. Mixed-Effects Models in S and S-PLUS , 2001 .
[15] Brian Whiting,et al. Experimental design and efficient parameter estimation in population pharmacokinetics , 1990, Journal of Pharmacokinetics and Biopharmaceutics.
[16] France Mentré,et al. Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model , 2006, Comput. Stat. Data Anal..
[17] Alain Mallet,et al. Optimal design in random-effects regression models , 1997 .
[18] Marc Lavielle,et al. Maximum likelihood estimation in nonlinear mixed effects models , 2005, Comput. Stat. Data Anal..
[19] D. Bates,et al. Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.
[20] France Mentré,et al. The SAEM algorithm for group comparison tests in longitudinal data analysis based on non‐linear mixed‐effects model , 2007, Statistics in medicine.
[21] Goonaseelan Pillai,et al. Non-Linear Mixed Effects Modeling – From Methodology and Software Development to Driving Implementation in Drug Development Science , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[22] France Mentré,et al. Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics , 2003, Journal of biopharmaceutical statistics.
[23] Lewis B. Sheiner,et al. Simultaneous vs. Sequential Analysis for Population PK/PD Data II: Robustness of Methods , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[24] Gordon Graham,et al. Optimal Design for Multiresponse Pharmacokinetic–Pharmacodynamic Models – Dealing with Unbalanced Designs , 2007, Journal of Pharmacokinetics and Pharmacodynamics.
[25] T. Louis. Finding the Observed Information Matrix When Using the EM Algorithm , 1982 .
[26] Sergei Leonov,et al. OPTIMAL POPULATION DESIGNS FOR PK MODELS WITH SERIAL SAMPLING , 2004, Journal of biopharmaceutical statistics.
[27] France Mentré,et al. Design in nonlinear mixed effects models: Optimization using the Fedorov–Wynn algorithm and power of the Wald test for binary covariates , 2007, Statistics in medicine.
[28] Michel Tod,et al. Evaluation of Uncertainty Parameters Estimated by Different Population PK Software and Methods , 2007, Journal of Pharmacokinetics and Pharmacodynamics.
[29] Kathryn Chaloner,et al. Bayesian Experimental Design for Nonlinear Mixed‐Effects Models with Application to HIV Dynamics , 2004, Biometrics.
[30] Leon Aarons,et al. Incorporating Correlation in Interindividual Variability for the Optimal Design of Multiresponse Pharmacokinetic Experiments , 2008, Journal of biopharmaceutical statistics.